ArticlePloS one2018

Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.

N Chantal Peltenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.